Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic Esophagitis.

Saved in:
Bibliographic Details
Title: Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic Esophagitis.
Authors: Nguyen JH; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Chehade M; Mount Sinai Center for Eosinophilic Disorders, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Dellon ES; University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Radin A; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Chittenden J; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Kamal MA; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Louisias M; Sanofi, Cambridge, Massachusetts, USA., Xu C; Sanofi, Morristown, New Jersey, USA., Kosloski MP; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2026 Jun; Vol. 119 (6), pp. 1555-1564. Date of Electronic Publication: 2026 Feb 26.
Publication Type: Journal Article; Clinical Trial, Phase III
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-6535
DOI:10.1002/cpt.70233